Fourteen people hospitalized after noodle shop unknowingly uses mysterious powder from waste site
Fourteen customers at a noodle shop in Udon Thani, Thailand became severely ill after consuming soup containing an unidentified white powder that was sourced from a waste site. The powder was brought to the shop employee by her brother, who believed it was cooking salt obtained from a local scrap collector. Authorities have collected samples for laboratory analysis, with results expected in approximately 20 days.
On Monday, fourteen diners at a noodle shop in Ban Phonsawan, Udon Thani province reported severe symptoms including stomach pain, nausea, difficulty breathing, seizures, and muscle contractions, with four requiring intensive care admission. Investigation revealed that shop employee Mrs. Boonliang, 55, had added a white powder to the soup after her brother told her it was cooking salt. The brother, Mr. Sinchu, 46, later admitted he obtained the powder from a local scrap collector's home, believing it to be table salt. Authorities traced the substance to a waste site, though its exact composition remains unknown. Police, forensics officers, and public health officials collected samples for laboratory testing, with results expected within approximately 20 days.
What's missing
The current health status of the fourteen victims is not provided; the article does not clarify whether all patients have been discharged, remain hospitalized, or if there have been any fatalities. Additionally, no information is given about whether the noodle shop has been closed pending investigation results.
What different sources said
- Bangkok PostCenter
Mystery powder in noodles leaves 14 sick
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.